SCHEMBL24100835

SCHEMBL24100835

O=C(O)c1nnsc1Sc1ccc(F)cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP7 Q93009 2/20 0.44
▸ MAPK14 Q16539 12/20 0.43
▸ USP10 Q14694 1/20 0.43
▸ USP47 Q96K76 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ MAPT P10636 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ DHFR P00374 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TTR P02766 1/20 0.34
▸ ALB P02768 1/20 0.34
▸ HMGB1 P09429 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24100851 0.81 MAPT (0.43) USP7MAPK14USP10USP47ALDH1A1
SCHEMBL24101222 0.80 KMT2A (0.46) ALDH1A1HSD17B10CYP1A2CYP2C9MAPT
SCHEMBL25996931 0.76 USP7 (0.39) USP7MAPK14USP10USP47
SCHEMBL24100866 0.76 L3MBTL1 (0.43) ALDH1A1HSD17B10CYP1A2CYP2C9KDM4E
SCHEMBL24101159 0.75 ITGB2 (0.44) USP7USP47ALDH1A1HSD17B10CYP1A2
SCHEMBL24100741 0.68 MEN1 (0.46) USP7ALDH1A1HSD17B10CYP1A2CYP2C9
SCHEMBL30452220 0.67 ALDH1A1 (0.46) USP7MAPK14USP10USP47ALDH1A1
SCHEMBL576377 0.67 ALDH1A1 (0.46) USP7MAPK14USP10USP47ALDH1A1
SCHEMBL24101228 0.67 POLB (0.43) ALDH1A1MAPTKDM4EKMT2A
SCHEMBL24101187 0.66 L3MBTL1 (0.55) HSD17B10CYP1A2CYP2C9MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233533-A1 COMPOSITIONS, METHODS OF TREATING AND PREVENTING FUNGAL INFECTIONS, AND METHODS OF INHIBITING PRP8 INTEIN EXPRESSION HEALTH RESEARCH, INC. (US) 2023-07-27 — — US disclosed
US-20230233533-A1 COMPOSITIONS, METHODS OF TREATING AND PREVENTING FUNGAL INFECTIONS, AND METHODS OF INHIBITING PRP8 INTEIN EXPRESSION HEALTH RESEARCH, INC. (US) 2023-07-27 — — US disclosed
WO-2021252068-A1 COMPOSITIONS, METHODS OF TREATING AND PREVENTING FUNGAL INFECTIONS, AND METHODS OF INHIBITING PRP8 INTEIN EXPRESSION HEALTH RESEARCH, INC. (US) 2021-12-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230233533-A1 COMPOSITIONS, METHODS OF TREATING AND PREVENTING FUNGAL INFECTIONS, AND METHODS OF INHIBITING PRP8 INTEIN EXPRESSION PRPF8, PRPF40A, PRPF19 USP7 668/4885MAPK14 2697/4885USP10 1879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback